A new copper IUD that provides long-lasting contraception and HIV prevention
A low-profile copper intrauterine device that delivers long-acting contraception an
This study is testing a new type of copper IUD that not only prevents pregnancy but also helps protect against HIV for up to three years, making it a great option for people who want both contraception and HIV prevention.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10898835 on NIH RePORTER |
What this research studies
This research focuses on developing a copper intrauterine device (IUD) that not only serves as a long-acting contraceptive but also delivers antiretroviral drugs to help prevent HIV infection. The approach involves creating a drug-eluting IUD that can provide effective contraception and HIV pre-exposure prophylaxis (PrEP) for up to three years. The research will evaluate the safety and effectiveness of this device through animal models, measuring how well the drug is delivered and its protective effects against HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are women of reproductive age who are at risk of unintended pregnancies and HIV infection.
Not a fit: Patients who are not at risk for HIV or those who do not require contraception may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide women with a highly effective method of preventing both unintended pregnancies and HIV infection.
How similar studies have performed: Other research has shown promise in developing multipurpose prevention technologies, but this specific approach using a copper IUD with drug delivery is relatively novel.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Woodrow, Kim a. — University of Washington
- Study coordinator: Woodrow, Kim a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.